117 related articles for article (PubMed ID: 33978213)
1. Chemoresistance in Malignant Intracranial Tumors: Longer Survival with Negative MDR1 Expression.
Ezgu MC; Kural C; Simsek GG; Kaygin P; Oguztuzun S; Kirik A; Yasar S; Kose G; Sarialtin SY; Coban T; Kul O
Turk Neurosurg; 2021; 31(3):447-459. PubMed ID: 33978213
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S-Transferases and Cytochrome P450 Enzyme Expression in Patients with Intracranial Tumors: Preliminary Report of 55 Patients.
Kural C; Kaya Kocdogan A; Şimşek GG; Oğuztüzün S; Kaygın P; Yılmaz I; Bayram T; Izci Y
Med Princ Pract; 2019; 28(1):56-62. PubMed ID: 30321868
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of P-glycoprotein and glutathione S-transferases in cerebral gliomas and response to chemotherapy.
von Bossanyi P; Diete S; Dietzmann K; Warich-Kirches M; Kirches E
Acta Neuropathol; 1997 Dec; 94(6):605-11. PubMed ID: 9444363
[TBL] [Abstract][Full Text] [Related]
4. Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance.
Lopes JM; Bruland OS; Bjerkehagen B; Silva MC; Holm R; Pettersen EO; Solheim OP; Sobrinho-Simões M; Nesland JM
Pathol Res Pract; 1997; 193(1):21-36. PubMed ID: 9112270
[TBL] [Abstract][Full Text] [Related]
5. Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes.
Tanaka S; Kamitani H; Amin MR; Watanabe T; Oka H; Fujii K; Nagashima T; Hori T
J Neurooncol; 2000; 46(2):157-71. PubMed ID: 10894369
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
Lacave R; Coulet F; Ricci S; Touboul E; Flahault A; Rateau JG; Cesari D; Lefranc JP; Bernaudin JF
Br J Cancer; 1998 Mar; 77(5):694-702. PubMed ID: 9514046
[TBL] [Abstract][Full Text] [Related]
7. [Treatment outcome of multidrug resistance related mRNA expression and c-jun-N-terminal kinase activity in patients with acute myeloid leukemia].
Do JH; Oh SH; Song EJ; Chung JS; Kang CD; Lee EY
Korean J Lab Med; 2007 Aug; 27(4):229-36. PubMed ID: 18094581
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
[TBL] [Abstract][Full Text] [Related]
9. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
10. Multifactorial drug-resistance phenomenon in acute leukemias: impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcome.
Goasguen JE; Lamy T; Bergeron C; Ly Sunaram B; Mordelet E; Gorre G; Dossot JM; Le Gall E; Grosbois B; Le Prisé PY; Fauchet R
Leuk Lymphoma; 1996 Nov; 23(5-6):567-76. PubMed ID: 9031088
[TBL] [Abstract][Full Text] [Related]
11. Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma?
Ashmore SM; Thomas DG; Darling JL
Anticancer Drugs; 1999 Nov; 10(10):861-72. PubMed ID: 10630353
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer.
Ikeda K; Sakai K; Yamamoto R; Hareyama H; Tsumura N; Watari H; Shimizu M; Minakami H; Sakuragi N
Int J Gynecol Cancer; 2003; 13(6):776-84. PubMed ID: 14675314
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of immunoexpression of the chemoresistance-related proteins in ependymomas: an analysis of 76 cases.
Korshunov A; Sycheva R; Timirgaz V; Golanov A
J Neurooncol; 1999; 45(3):219-27. PubMed ID: 10845392
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance in brain tumors: roles of the blood-brain barrier.
Régina A; Demeule M; Laplante A; Jodoin J; Dagenais C; Berthelet F; Moghrabi A; Béliveau R
Cancer Metastasis Rev; 2001; 20(1-2):13-25. PubMed ID: 11831641
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
[TBL] [Abstract][Full Text] [Related]
16. A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients.
Schaich M; Kestel L; Pfirrmann M; Robel K; Illmer T; Kramer M; Dill C; Ehninger G; Schackert G; Krex D
Ann Oncol; 2009 Jan; 20(1):175-81. PubMed ID: 18687982
[TBL] [Abstract][Full Text] [Related]
17. Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma.
Liu X; Chen L; Feng B; Liu G
Anat Rec (Hoboken); 2014 Feb; 297(2):215-21. PubMed ID: 24376145
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer: pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics.
Buser K; Joncourt F; Altermatt HJ; Bacchi M; Oberli A; Cerny T
Ann Oncol; 1997 Apr; 8(4):335-41. PubMed ID: 9209662
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein, glutathione and glutathione S-transferase increase in a colon carcinoma cell line by colchicine.
Ruiz-Gómez MJ; Souviron A; Martínez-Morillo M; Gil L
J Physiol Biochem; 2000 Dec; 56(4):307-12. PubMed ID: 11321524
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase and P-glycoprotein expressions in neuroblastoma.
Kutlik MT; Ayhan A; Göğüş S; Yalçin B; Cağlar M; Büyükpamukçu M
Pediatr Hematol Oncol; 2002; 19(5):337-45. PubMed ID: 12078865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
